Vipul Organics Q1 FY27 Results (BSE: 530627)
Signal: Growth reaccelerated
The read
The operating inflection is stronger annual growth—revenue ₹51.78 Cr, +37.7% YoY—combined with EBITDA of ₹5.39 Cr, +39.3% YoY, and EBIT of ₹3.97 Cr, +71.1% YoY; however, QoQ revenue fell 0.85% and EPS growth of 54.7% lagged PAT growth of 100.8%, so sustained demand momentum and the share-count bridge remain the key checks.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹51.78 Cr | 37.7% | -0.85% |
| EBIT | ₹3.97 Cr | 71.1% | |
| Net profit | ₹2.53 Cr | 100.8% | |
| EPS | ₹1.33 | 54.7% | |
| EBIT margin | 10.4% |
P&L walk
Consolidated revenue rose 37.7% YoY to ₹51.78 Cr but fell 0.85% QoQ, EBITDA increased 39.3% to ₹5.39 Cr with a 10.4% margin, EBIT grew 71.1% to ₹3.97 Cr and PAT doubled to ₹2.53 Cr; management attributes margin improvement to cost optimization.
Key positives
- Revenue reached ₹5217.52 lakh, up 38.44% YoY, accelerating sharply from the prior-quarter revenue growth of 18.4% YoY.
- EBIT grew 71.1% YoY to ₹3.97 Cr versus revenue growth of 37.7%, indicating materially improved operating conversion.
- PAT increased 99.75% YoY to ₹252.46 lakh and 27.93% QoQ, while other income of ₹0.4 Cr remained modest relative to PBT of ₹3.44 Cr.
- Management states that cost optimization is beginning to translate into margin expansion and that the capex cycle is complete.
- The membrane division is stated to remain on track and is expected to add a new revenue stream.
Key concerns
- Revenue declined 0.85% QoQ to ₹5217.52 lakh despite 37.7% YoY growth, indicating sequential momentum moderated.
- EPS rose 54.65% YoY to ₹1.33, materially below PAT growth of 99.75%, requiring monitoring for dilution or minority-interest effects.
- The release provides no quantified membrane revenue contribution, capacity, launch timing or return targets, limiting visibility on the diversification thesis.
Research and educational content only. Not investment advice.